Lavaud, P., Saada-Bouzid, E., Sabatier, R., Saux, O. L., Rouge, T. d. l. M., Gonçalves, A., . . . Charafe, E. Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: An open-label phase I/II study. BMJ Publishing Group.
Chicago Style (17th ed.) CitationLavaud, Pernelle, et al. Durvalumab and Tremelimumab in Combination with Metronomic Oral Vinorelbine for Recurrent Advanced Cervical Cancer: An Open-label Phase I/II Study. BMJ Publishing Group.
MLA (9th ed.) CitationLavaud, Pernelle, et al. Durvalumab and Tremelimumab in Combination with Metronomic Oral Vinorelbine for Recurrent Advanced Cervical Cancer: An Open-label Phase I/II Study. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.